nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—NR3C1—bipolar disorder	0.931	1	CbGaD
Fluocinolone Acetonide—PLA2G4A—blood plasma—bipolar disorder	0.00855	0.162	CbGeAlD
Fluocinolone Acetonide—SERPINA6—blood plasma—bipolar disorder	0.00852	0.161	CbGeAlD
Fluocinolone Acetonide—NR3C1—urine—bipolar disorder	0.00715	0.135	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adrenal cortex—bipolar disorder	0.00434	0.0821	CbGeAlD
Fluocinolone Acetonide—NR3C1—blood plasma—bipolar disorder	0.00373	0.0706	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—thyroid gland—bipolar disorder	0.00302	0.0572	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—nervous system—bipolar disorder	0.00254	0.0481	CbGeAlD
Fluocinolone Acetonide—SERPINA6—nervous system—bipolar disorder	0.00253	0.0479	CbGeAlD
Fluocinolone Acetonide—SERPINA6—cerebellum—bipolar disorder	0.00238	0.0451	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—brain—bipolar disorder	0.00194	0.0368	CbGeAlD
Fluocinolone Acetonide—SERPINA6—brain—bipolar disorder	0.00194	0.0366	CbGeAlD
Fluocinolone Acetonide—NR3C1—adrenal cortex—bipolar disorder	0.00189	0.0358	CbGeAlD
Fluocinolone Acetonide—NR3C1—thyroid gland—bipolar disorder	0.00132	0.025	CbGeAlD
Fluocinolone Acetonide—NR3C1—nervous system—bipolar disorder	0.00111	0.021	CbGeAlD
Fluocinolone Acetonide—NR3C1—cerebellum—bipolar disorder	0.00104	0.0197	CbGeAlD
Fluocinolone Acetonide—NR3C1—brain—bipolar disorder	0.000848	0.016	CbGeAlD
Fluocinolone Acetonide—Difluprednate—NR3C1—bipolar disorder	0.000638	0.0567	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—bipolar disorder	0.000619	0.055	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—bipolar disorder	0.000586	0.052	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—bipolar disorder	0.000586	0.052	CrCbGaD
Fluocinolone Acetonide—Desoximetasone—NR3C1—bipolar disorder	0.000571	0.0507	CrCbGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—bipolar disorder	0.0005	0.0444	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—bipolar disorder	0.000492	0.0437	CrCbGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—bipolar disorder	0.000484	0.043	CrCbGaD
Fluocinolone Acetonide—Budesonide—NR3C1—bipolar disorder	0.00045	0.0399	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—bipolar disorder	0.00045	0.0399	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—bipolar disorder	0.000441	0.0392	CrCbGaD
Fluocinolone Acetonide—Mometasone—NR3C1—bipolar disorder	0.000428	0.038	CrCbGaD
Fluocinolone Acetonide—Rimexolone—NR3C1—bipolar disorder	0.000423	0.0375	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—bipolar disorder	0.000399	0.0354	CrCbGaD
Fluocinolone Acetonide—Beclomethasone—NR3C1—bipolar disorder	0.000399	0.0354	CrCbGaD
Fluocinolone Acetonide—Alclometasone—NR3C1—bipolar disorder	0.000388	0.0344	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—bipolar disorder	0.000378	0.0335	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—bipolar disorder	0.000378	0.0335	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—bipolar disorder	0.000378	0.0335	CrCbGaD
Fluocinolone Acetonide—Paramethasone—NR3C1—bipolar disorder	0.000373	0.0331	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—NR3C1—bipolar disorder	0.000364	0.0323	CrCbGaD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—bipolar disorder	0.000352	0.0312	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—NR3C1—bipolar disorder	0.000297	0.0263	CrCbGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR1D1—bipolar disorder	0.000267	0.0548	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—bipolar disorder	0.000265	0.0235	CrCbGaD
Fluocinolone Acetonide—Prednisolone—NR3C1—bipolar disorder	0.000248	0.022	CrCbGaD
Fluocinolone Acetonide—Betamethasone—NR3C1—bipolar disorder	0.000243	0.0216	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Ca-dependent events—ADCY2—bipolar disorder	0.000208	0.0428	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR1D1—bipolar disorder	0.000206	0.0424	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—NR1D1—bipolar disorder	0.000194	0.0399	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—bipolar disorder	0.000181	0.0371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PLC beta mediated events—ADCY2—bipolar disorder	0.000153	0.0315	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—G-protein mediated events—ADCY2—bipolar disorder	0.000151	0.0309	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.00015	0.0309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—TRPC3—bipolar disorder	0.000147	0.0303	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—bipolar disorder	0.000141	0.0125	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—PDE4B—bipolar disorder	0.000133	0.0273	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—CLOCK—bipolar disorder	0.000132	0.027	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—ADCY2—bipolar disorder	0.000115	0.0236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—ADCY2—bipolar disorder	9.41e-05	0.0193	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—DGKH—bipolar disorder	9.24e-05	0.019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3C2A—bipolar disorder	7.74e-05	0.0159	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—bipolar disorder	7.52e-05	0.0154	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TCF7L2—bipolar disorder	7.45e-05	0.0153	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—bipolar disorder	7.45e-05	0.0153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	6.41e-05	0.0132	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	6.11e-05	0.0126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—INS—bipolar disorder	6.1e-05	0.0125	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—bipolar disorder	5.97e-05	0.0123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	5.6e-05	0.0115	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TACR1—bipolar disorder	5.57e-05	0.0114	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TPH2—bipolar disorder	5.57e-05	0.0114	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—bipolar disorder	5.22e-05	0.0107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—POMC—bipolar disorder	5.21e-05	0.0107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	5.16e-05	0.0106	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—GATA3—bipolar disorder	5.15e-05	0.0106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—DGKH—bipolar disorder	4.76e-05	0.00978	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	4.71e-05	0.00968	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	4.61e-05	0.00946	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TAC1—bipolar disorder	4.54e-05	0.00932	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	4.45e-05	0.00914	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—GATA3—bipolar disorder	4.45e-05	0.00914	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	4.45e-05	0.00914	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	4.33e-05	0.00889	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	4.24e-05	0.00871	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	4.23e-05	0.00869	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	3.89e-05	0.00798	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—IMPA2—bipolar disorder	3.77e-05	0.00775	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—bipolar disorder	3.68e-05	0.00755	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—bipolar disorder	3.65e-05	0.00749	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR1D1—bipolar disorder	3.56e-05	0.00732	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—MAOA—bipolar disorder	3.35e-05	0.00688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TRPC3—bipolar disorder	3.3e-05	0.00678	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—BDNF—bipolar disorder	3.23e-05	0.00664	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINA1—bipolar disorder	2.89e-05	0.00593	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	2.87e-05	0.00589	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DGKH—bipolar disorder	2.73e-05	0.00561	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	2.73e-05	0.00561	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—IMPA1—bipolar disorder	2.55e-05	0.00523	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—INS—bipolar disorder	2.51e-05	0.00515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD5—bipolar disorder	2.5e-05	0.00513	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	2.49e-05	0.00511	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GATA3—bipolar disorder	2.45e-05	0.00504	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RGS4—bipolar disorder	2.45e-05	0.00504	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NDUFV2—bipolar disorder	2.17e-05	0.00445	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C4—bipolar disorder	2.1e-05	0.00431	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TRPC3—bipolar disorder	1.9e-05	0.00389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NR1D1—bipolar disorder	1.89e-05	0.00387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADM—bipolar disorder	1.81e-05	0.00371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCAN—bipolar disorder	1.8e-05	0.0037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A3—bipolar disorder	1.77e-05	0.00363	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TSHB—bipolar disorder	1.76e-05	0.00362	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TACR1—bipolar disorder	1.76e-05	0.00362	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PDE4B—bipolar disorder	1.76e-05	0.00362	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C4—bipolar disorder	1.76e-05	0.0036	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1D1—bipolar disorder	1.72e-05	0.00352	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—bipolar disorder	1.62e-05	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DGKH—bipolar disorder	1.62e-05	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD5—bipolar disorder	1.48e-05	0.00303	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR1A—bipolar disorder	1.46e-05	0.00299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RGS4—bipolar disorder	1.45e-05	0.00297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TAC1—bipolar disorder	1.44e-05	0.00295	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD1—bipolar disorder	1.41e-05	0.00289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2C—bipolar disorder	1.41e-05	0.00289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD3—bipolar disorder	1.36e-05	0.0028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD4—bipolar disorder	1.32e-05	0.00272	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CLOCK—bipolar disorder	1.28e-05	0.00262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADCY2—bipolar disorder	1.25e-05	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TSHB—bipolar disorder	1.24e-05	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TPH2—bipolar disorder	1.24e-05	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CACNB2—bipolar disorder	1.24e-05	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—DRD2—bipolar disorder	1.23e-05	0.00253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DPYD—bipolar disorder	1.22e-05	0.00251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CACNA1C—bipolar disorder	1.14e-05	0.00234	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRPC3—bipolar disorder	1.12e-05	0.0023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3C2A—bipolar disorder	1.11e-05	0.00228	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.09e-05	0.00225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADM—bipolar disorder	1.07e-05	0.00219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4B—bipolar disorder	1.04e-05	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSHB—bipolar disorder	1.04e-05	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TACR1—bipolar disorder	1.04e-05	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SNAP25—bipolar disorder	9.95e-06	0.00204	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADCY2—bipolar disorder	8.81e-06	0.00181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—bipolar disorder	8.64e-06	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR1A—bipolar disorder	8.62e-06	0.00177	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TAC1—bipolar disorder	8.49e-06	0.00174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD1—bipolar disorder	8.32e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2C—bipolar disorder	8.32e-06	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—bipolar disorder	8.09e-06	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD3—bipolar disorder	8.06e-06	0.00165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3A—bipolar disorder	8.02e-06	0.00165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD4—bipolar disorder	7.82e-06	0.00161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COMT—bipolar disorder	7.54e-06	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MAOA—bipolar disorder	7.49e-06	0.00154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADCY2—bipolar disorder	7.36e-06	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TCF7L2—bipolar disorder	7.34e-06	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DRD2—bipolar disorder	7.29e-06	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—bipolar disorder	6.9e-06	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK1—bipolar disorder	6.6e-06	0.00135	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—S100B—bipolar disorder	6.41e-06	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—bipolar disorder	6.1e-06	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRG1—bipolar disorder	5.66e-06	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—bipolar disorder	5.1e-06	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—bipolar disorder	4.88e-06	0.001	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—bipolar disorder	4.85e-06	0.000995	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3B—bipolar disorder	4.11e-06	0.000844	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—bipolar disorder	4.08e-06	0.000837	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—bipolar disorder	4.05e-06	0.000832	CbGpPWpGaD
